273 related articles for article (PubMed ID: 24755524)
1. Design, synthesis and preliminary evaluation of α-sulfonyl γ-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.
Zhang J; Li X; Jiang Y; Feng J; Li X; Zhang Y; Xu W
Bioorg Med Chem; 2014 Jun; 22(11):3055-64. PubMed ID: 24755524
[TBL] [Abstract][Full Text] [Related]
2. Novel potent 2,5-pyrrolidinedione peptidomimetics as aminopeptidase N inhibitors. Design, synthesis and activity evaluation.
Li Q; Fang H; Wang X; Hu G; Wang Q; Xu W
Bioorg Med Chem Lett; 2012 Jan; 22(2):850-3. PubMed ID: 22206607
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and preliminary activity evaluation of novel peptidomimetics as aminopeptidase N/CD13 inhibitors.
Li X; Wang J; Zhang L; Xu W
Arch Pharm (Weinheim); 2011 Aug; 344(8):494-504. PubMed ID: 21681811
[TBL] [Abstract][Full Text] [Related]
4. Sulfonyl phosphonic 1,4-dithia-7-azaspiro[4,4]nonane derivatives as matrix metalloproteinase inhibitors: Synthesis, a docking study, and biological evaluation.
Zhang H; Li X; Wang X; Xu W; Zhang J
Drug Discov Ther; 2017; 11(3):118-125. PubMed ID: 28757512
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of novel L-isoserine tripeptide derivatives as aminopeptidase N inhibitors.
Pan H; Yang K; Zhang J; Xu Y; Jiang Y; Yuan Y; Zhang X; Xu W
J Enzyme Inhib Med Chem; 2013 Aug; 28(4):717-26. PubMed ID: 22545941
[TBL] [Abstract][Full Text] [Related]
6. Progress towards water-soluble triazole-based selective MMP-2 inhibitors.
Fabre B; Filipiak K; Zapico JM; Díaz N; Carbajo RJ; Schott AK; Martínez-Alcázar MP; Suárez D; Pineda-Lucena A; Ramos A; de Pascual-Teresa B
Org Biomol Chem; 2013 Oct; 11(38):6623-41. PubMed ID: 23989288
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel amino acid ureido derivatives as aminopeptidase N/CD13 inhibitors.
Su L; Jia Y; Zhang L; Xu Y; Fang H; Xu W
Bioorg Med Chem; 2012 Jun; 20(12):3807-15. PubMed ID: 22607877
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
Cheng XC; Wang Q; Fang H; Tang W; Xu WF
Bioorg Med Chem; 2008 May; 16(10):5398-404. PubMed ID: 18440232
[TBL] [Abstract][Full Text] [Related]
9. Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.
Yan XQ; Wang ZC; Li Z; Wang PF; Qiu HY; Chen LW; Lu XY; Lv PC; Zhu HL
Bioorg Med Chem Lett; 2015 Oct; 25(20):4664-71. PubMed ID: 26346367
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
Cheng XC; Wang Q; Fang H; Tang W; Xu WF
Bioorg Med Chem; 2008 Sep; 16(17):7932-8. PubMed ID: 18718763
[TBL] [Abstract][Full Text] [Related]
11. Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.
Shi L; Wang Q; Wang H; Zhou H; Li Y; Li X
Bioorg Med Chem; 2013 Dec; 21(24):7752-62. PubMed ID: 24247003
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.
Zhang X; Zhang J; Zhang L; Feng J; Xu Y; Yuan Y; Fang H; Xu W
Bioorg Med Chem; 2011 Oct; 19(20):6015-25. PubMed ID: 21911297
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and preliminary evaluation of novel pyrrolidine derivatives as matrix metalloproteinase inhibitors.
Cheng XC; Wang Q; Fang H; Tang W; Xu WF
Eur J Med Chem; 2008 Oct; 43(10):2130-9. PubMed ID: 18362041
[TBL] [Abstract][Full Text] [Related]
14. A pentanoic acid derivative targeting matrix metalloproteinase-2 (MMP-2) induces apoptosis in a chronic myeloid leukemia cell line.
Mukherjee A; Adhikari N; Jha T
Eur J Med Chem; 2017 Dec; 141():37-50. PubMed ID: 29028530
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, Biological Evaluation, and Docking of Dihydropyrazole Sulfonamide Containing 2-hydroxyphenyl Moiety: A Series of Novel MMP-2 Inhibitors.
Wang PF; Qiu HY; Baloch SK; Gong HB; Wang ZC; Zhu HL
Chem Biol Drug Des; 2015 Dec; 86(6):1405-10. PubMed ID: 26061284
[TBL] [Abstract][Full Text] [Related]
16. A novel aminopeptidase N inhibitor developed by virtual screening approach.
Feng J; Jin K; Zhu H; Zhang X; Zhang L; Liu J; Xu W
Bioorg Med Chem Lett; 2012 Sep; 22(18):5863-9. PubMed ID: 22901392
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.
Wang Q; Chen M; Zhu H; Zhang J; Fang H; Wang B; Xu W
Bioorg Med Chem; 2008 May; 16(10):5473-81. PubMed ID: 18467109
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of Novel Hybrids Inspired from Bromopyrrole Alkaloids Inhibiting MMP-2 and -12 as Antineoplastic Agents.
Rane RA; Naphade SS; Bangalore PK; Palkar MB; Patel HM; Shaikh MS; Alwan WS; Karpoormath R
Chem Biol Drug Des; 2015 Aug; 86(2):210-22. PubMed ID: 25418204
[TBL] [Abstract][Full Text] [Related]
19. Novel leucine ureido derivatives as aminopeptidase N inhibitors. Design, synthesis and activity evaluation.
Ma C; Cao J; Liang X; Huang Y; Wu P; Li Y; Xu W; Zhang Y
Eur J Med Chem; 2016 Jan; 108():21-27. PubMed ID: 26629857
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and evaluation of novel metalloproteinase inhibitors based on L-tyrosine scaffold.
Cheng XC; Wang RL; Dong ZK; Li J; Li YY; Li RR
Bioorg Med Chem; 2012 Oct; 20(19):5738-44. PubMed ID: 22967811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
